Trial Profile
A pilot, double-blind, randomised, placebo controlled study to evaluate the efficacy of Azelastine/fluticasone propionate (Dymista) for the treatment of non-allergic rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary)
- Indications Rhinitis
- Focus Registrational; Therapeutic Use
- 15 Mar 2016 New trial record
- 07 Mar 2016 Results (n=30) presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.